跳至主要内容
临床试验/NCT00392366
NCT00392366已完成不适用

The Clinical Evaluation of the Laser Interstitial Thermal Therapy (LITT ), Under "Real Time" MRI Guidance, for the "Minimal Invasive" Treatment of Liver Metastasis - a Phase IIa Mono-centric Study, Without Direct Benefice to the Patient

BioTex, Inc.2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2006年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
BioTex, Inc.
入组人数
25
试验地点
2
主要终点
Accuracy of predicted lesion geometry to histologically measured dimensions

研究概览

简要总结

The purpose of this study is to determine if the, MR guided, laser interstitial thermal therapy (LITT) treatment technique can be safety and efficiently used for the human liver metastasis

详细描述

This new "minimally invasive" technique has been tested so far, with success, on animal brain and prostate tumors. LITT has also tested with success by other teams for the treatment of liver metastasis.

The main purpose of this study is to determine if the Visualase, MR guided, laser interstitial thermal therapy device can be safely and efficiently used for the treatment of human liver metastasis originating from the colon and rectal primary tumors.

As secondary objectives for this clinical study is to explore the tolerance of the treatment and its contra indications.

The clinical trial will include a statistical sample of 25 patients and will run over a period of 24 months. The inclusion period will be of 12 months and the patients will be followed up during a period of 7 days after the intervention.

The clinical trial will be performed at the Cochin University Hospital of Paris and the patients will be coming from the oncology / surgery departments of the hospital.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients 18 years of age or older
  • Patients with liver metastasis, originating from colon and liver cancer and proved by histological analysis
  • Patient that are scheduled for a surgical resection of part of the liver,
  • Patient having a liver metastasis, originating from colon and rectal cancer, smaller or equal to 3 cm
  • Patients having the liver metastasis at a distance of at least 1 cm or from the hepatic capsule or/and from a vascular structure

排除标准

  • Patients younger than 18 years old
  • Patients presenting contra indication for MRI studies
  • Patient presenting contra indication to liver surgery
  • Patients who already had other interstitial treatment on the targeted lesion

结局指标

主要结局

Accuracy of predicted lesion geometry to histologically measured dimensions

次要结局

未报告次要终点

研究者

发起方
BioTex, Inc.
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验